Showing posts with label DIA's Annual Canada Meeting. Show all posts
Showing posts with label DIA's Annual Canada Meeting. Show all posts

Thursday, October 10, 2013

Insights From Canada’s Thought Leaders on Patient’s Voice, Plain Language Labeling Project, Pharmacovigilance

News
& PublicationsMeetings & TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting
AdvertisingCareer Center
Exclusive Scoop from Canada's Key Thought Leaders
     
In this edition of the Insider Update you’ll hear insights from Canada’s key industry thought leaders regarding the impact of patient’s voice in the ever changing regulatory environment, the emerging areas of change in Pharmacovigilance in Canada, and what international regulatory cooperation means to key stakeholders in the development and regulation of health products. In addition, we will address the need to provide the patient and the health care professional with increased accessibility to drug information and comprehension of drug labels, plus more.
 
“Those who are in the pharmaceutical industry and those in the regulatory realm
need to acknowledge the patients’ voice and perspective."

"New approaches and collaborations are required to keep up with the
realities of the pharmaceutical industry today..."
Get the Insider Scoop NOW!
   Read More Insider Update



Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

Thursday, October 3, 2013

DIA's Annual Canadian Meeting: New Reality/New Frontiers

News & PublicationsMeetings & TrainingsSpeaking & PublishingNetworking
& CommunitiesExhibiting AdvertisingCareer Center
 
DIA's Annual Canadian Meeting: New Reality/New Frontiers
DIA Members Save $150. Early-bird expires October 7.
Collaborate with key stakeholders: boost awareness and deliver value to today’s patient reality driving change in drug development and regulations. At this Annual Meeting, stakeholders from industry, regulatory agencies, academic researchers, patient and patient advocacy groups will have the opportunity to work together to recognize the challenges faced by the industry and regulators in drug development, market access, and regulations in Canada. 
Opening Remarks:
Kathryn McDade
Assistant Deputy Minister of the Health Products and Food Branch
Health Canada
Plenary Sessions:
    • International Regulatory Cooperation
           - Trends and Impacts
           - Stakeholder Perspective
Register 3, Get the 4th FREE!
Register three individuals from the same company and receive complimentary registration for a fourth! All four individuals must register and prepay at the same time.
Table Top Exhibits:
Showcase your products and services to key decision makers in Canada. View Application Now.
Email Preferences    |    My DIA    |    Forward to a Friend    |    FacebookLinkedInTwitterYouTubeFlickr


Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.